Tom Price bought Innate Immunotherapeutics, Ltd. (--)
Tom Price (R-GA), a U.S. Representative, has disclosed 180 trades in Innate Immunotherapeutics, Ltd. (--) since 2014, 105 purchases and 75 sales, worth an estimated $3.3M in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a purchase: Tom Price bought $50,001 - $100,000 of Innate Immunotherapeutics, Ltd. (--) on August 31, 2016. Since that trade, -- is up +0.00% against the S&P 500 up +302.77%, an outperformance of -302.77%.
Across these filings, Tom Price has been a net buyer of -- (a buy-to-sell ratio of 1.40). Each row in the table below links to that trade and its post-trade performance versus the market.
Data updated
Tom Price's -- trades vs the price
-- is up +0.00% since Tom Price bought on August 31, 2016, versus +302.77% for the S&P 500.
Performance since this trade
All Tom Price -- trades
Estimated profit is shown for buys only, marked to the latest close. It is an estimate and does not net later sells, taxes, or fees.
Tom Price & -- trading FAQ
Is it legal for Tom Price to trade Innate Immunotherapeutics, Ltd. (--) stock?
Yes. Members of Congress are allowed to trade individual stocks, including Innate Immunotherapeutics, Ltd. (--), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. BullishWhales tracks those disclosures; this page does not imply the trade was improper.
When did Tom Price buy --?
Tom Price disclosed a purchase of $50,001 - $100,000 of Innate Immunotherapeutics, Ltd. (--) on August 31, 2016, according to public STOCK Act filings.
How has -- performed since Tom Price's trade?
Since Tom Price bought -- on August 31, 2016, the stock is up +0.00%, versus +302.77% for the S&P 500 over the same period, an outperformance of -302.77%.
How many times has Tom Price traded --?
Tom Price has disclosed 180 -- trades since 2014 (105 purchases and 75 sales). Every disclosed trade is listed on this page.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional -- trades?
BullishWhales tracks every disclosed congressional trade in Innate Immunotherapeutics, Ltd. (--) on the Innate Immunotherapeutics, Ltd. congressional trading page, which aggregates filings across all members of Congress.
Tom Price's -- tradesAll congressional filings for Innate Immunotherapeutics, Ltd.Tom Price's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.